Glass House Brands (GLAS) Change in Cash (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Change in Cash of $4.6 million for Q1 2026, up 561.42% year-over-year from $692000.0 in Q1 2025, and up 171.28% quarter-over-quarter from -$6.4 million in Q4 2025.
Glass House Brands (GLAS) Change in Cash (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Change in Cash for 7 consecutive years, with $4.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash rose 561.42% year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at -$9.7 million (down 173.36% YoY), while the FY2025 annual figure was -$13.6 million, down 408.55% from the prior year.
- Change in Cash advanced to $4.6 million in Q1 2026 per GLAS's latest filing, from -$6.4 million in the prior quarter.
- Across five years, Change in Cash topped out at $23749.3 billion in Q3 2023 and bottomed at -$29234.1 billion in Q4 2022.
- Historically, Change in Cash has averaged -$322.6 billion across 5 years, with a median of $1.9 million in 2024.
- Annual changes were most pronounced in 2023 — Change in Cash jumped 27940376370.59% — and 2024, when it slumped 464.81%.
- Glass House Brands' Change in Cash stood at -$29234.1 billion in 2022, then jumped by 100.0% to -$5.4 million in 2023, then jumped by 134.7% to $1.9 million in 2024, then slumped by 444.66% to -$6.4 million in 2025, then soared by 171.28% to $4.6 million in 2026.
- Business Quant data shows GLAS's Change in Cash at $4.6 million in Q1 2026, -$6.4 million in Q4 2025, and -$14.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Glass House Brands | 866.27 Mn | 847.71 Mn | 15.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.58 Mn |
| Dec 31, 2025 | -6.42 Mn |
| Sep 30, 2025 | -14.43 Mn |
| Jun 30, 2025 | 6.59 Mn |
| Mar 31, 2025 | 692,000.00 |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | 9.18 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | -8.12 Mn |
| Dec 31, 2023 | -5.37 Mn |
| Sep 30, 2023 | 23,749.32 Bn |
| Jun 30, 2023 | 6.32 Mn |
| Mar 31, 2023 | 2.22 Mn |
| Dec 31, 2022 | -29,234.08 Bn |
| Sep 30, 2022 | 85,000.00 |
| Jun 30, 2022 | 7.38 Mn |
| Mar 31, 2022 | 29.23 Mn |
| Dec 31, 2021 | 49,531.58 Bn |
| Sep 30, 2021 | 104.51 Mn |
| Jun 30, 2021 | 122.67 Mn |